Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2006-12-22
2010-08-17
Lukton, David (Department: 1654)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
C530S317000, C540S001000
Reexamination Certificate
active
07777030
ABSTRACT:
The present invention relates to various novel substituted dipeptide derived nitrogen-containing heterocyclic compounds, their pharmaceutically acceptable salt derivatives, and their methods of use. In one aspect the present invention relates to compositions and methods for the treatment and prevention of disease in a mammal comprising administering the compounds of the invention in a pharmaceutically acceptable form to a mammal. In particular, the invention relates to medicaments comprising various novel substituted dipeptide derived nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salt derivatives and methods for administration to a mammal for the treatment and prevention of malarial diseases. The compounds of the invention may optionally be administered with at least one pharmaceutically acceptable excipient, another biologically active agent or a combination thereof.
REFERENCES:
patent: 3637811 (1972-01-01), Zenner
patent: 4003912 (1977-01-01), Franz
patent: 4178371 (1979-12-01), Morgan
patent: 4680338 (1987-07-01), Sundoro
patent: 4918186 (1990-04-01), Kajimoto
patent: 4929736 (1990-05-01), Groutas
patent: 5508400 (1996-04-01), Wilkerson
patent: 5532356 (1996-07-01), Smyser
patent: 5532357 (1996-07-01), Rodgers
patent: 7060845 (2006-06-01), Guichard
patent: 2005/0038105 (2005-02-01), Guichard
patent: 2847760 (1980-05-01), None
patent: 0533200 (1993-03-01), None
patent: 0765873 (1997-04-01), None
patent: 0858999 (1998-08-01), None
patent: WO 93/07128 (1993-04-01), None
patent: WO 93/09133 (1993-05-01), None
patent: WO 94/08977 (1994-04-01), None
patent: WO 94/22840 (1994-10-01), None
patent: WO 95/02582 (1995-01-01), None
patent: WO 96/29329 (1996-09-01), None
patent: WO 01/90083 (2001-11-01), None
patent: WO 01/96318 (2001-12-01), None
patent: WO 02/28842 (2002-04-01), None
patent: WO 03/103677 (2003-12-01), None
patent: WO 2007/074169 (2007-07-01), None
patent: WO 2007/074170 (2007-07-01), None
patent: WO 2007/074171 (2007-07-01), None
English Abstract of JP 062,195,361, Feb. 1988.
English Abstract of FR 002,810,039, Dec. 2001.
Savarino A, Gennero L, Chen HC, Serrano D, Malavasi F, Boelaert JR, Sperber K. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS Nov. 23, 2001;15(17):2221-9.
Savarino A, et al., The Anti-HIV-1 Activity of Chloroquine, Journal of Clinical Virology, vol. 20; Feb. 2001; pp. 131-135.
Morpurgo et al., N-hydroxysuccinimide Carbonates and Carbamates Are Useful Reactive Reagents for Coupleing Ligands to Lysines on Proteins. J. Biochem. Biophys. Methods, 38:17-28 (1999).
Kruijtzer et al., Approaches to the Synthesis of Ureapeptoid Peptidomimetics. Tetrahedron Letters, 38(30):5335-5338 (1997).
Richter et al., Curtius Degradation in Solid-Phase Synthesis. Tetrahedron Letters, 39:8747-8750 (1998).
Neel et al., Synthesis of a 3-Keto Bicyclic Pyrazolidinone Using a Curtius Rearrangement. Tetrahedron Letters, 37(28):4891-4894 (1996).
Conroy et al., Using the Electrostatic Field Effect to Design a New Class of Inhibitors for Cystein Proteases. Journal of the American Chemical Society, 119:4285-4291 (1997).
Shiori et al., Diphenylphosphoryl Azide. A New Convenient Reagent for a Modified Curtius Reaction and for the Peptide Synthesis. Journal of the American Chemical Society, 94:17 (1972).
Burgess et al., Solid Phase Synthesis of Oligoureas. Journal of the American Chemical Society, 119(7):1556-1564 (1997).
Corral et al., Synthesis of 5-amino-2,3-dihydro-1H-1,4-benzodiazepines. Journal of Heterocyclic Chemistry, 14:985 (1977).
Martinez et al., Activated N-Nitrosocarbamates for Regioselective Synthesis of N-Nitrosoureas. Journal of Medicinal Chemistry, 25:178-182 (1982).
Kim et al.,The Solid Phase Synthesis of Oligoureas. Tetrahedron Letters, 37(30):5305-5308 (1996).
Wilson et al., An Efficient Synthesis of N,N-Linked Oligoureas. Tetrahedron Letter, 39(37):6613-6616 (1998).
Lena et al., “1,3,5-Triazepan-2,6-Diones As Structurally Diverse and Conformationaly Constrained Dipeptide Mimetics: Identification of Malaria Liver Stage Inhibitors From a Small Pilot Library,” Chemistry—A European Journal, vol. 12 No. 33 Nov. 2006, pp. 8498-8512.
Semetey, Vincent et al. “O-Succinimidyl Carbamate Derivatives From Amino Acids and Peptides: A General Entry to Urea-Based Peptidomimetics,” Proceedings of the European Peptide Symposium, 26thMontpellier, France, Sep. 10-15, 2003, Publisher: Editions EDK, Paris, Fr. Coden: 69EDWK; IS, 2003.
Boilard Eric et al. “Secreted Phospholipase A2 Inhibitors Are Also Potent Blockers of Binding to the M-Type Recepter,” Biochemistry, 45(44), 13203-13218 Coden: Bichaw; ISSN: 0006-2960, 2006, XP002451620, p. 13212, compound 19.
Lin et al., Acyclic Structural Variants of Growth Hormone Secretagogue L-692,429; Bioorganic & Medicinal Chemistry Letters. 9(22):3237-3242 (1999).
Guichard et al., Effective Preparation of O-succinimidyl-2-(tert-butoxycarbonylamino)ethylcarbamate Derivatives from β-Aminio Acids. Application to the Synthesis of Urea-Containing Pseudopeptides and Oligoureas; Journal of Organic Chemistry. 64(23):8702-8705 (1999).
Guichard et al., Solid Phase Synthesis of Oligoureas Using 0-Succinimidy1-9H-Fluoren-9-ylmethoxycarbonylaminio)ethylcarbamate Derivatives As Activated Monomers. Tetrahedron Letters, 41(10):1553-1557 (2000).
Guha and Ramaswami, Attempts to Synthesize Uric Acid From Nine-Membered Cycloids. J. Indian Chem. Soc. 11:811-822 (1934).
Tamilarasu et al., Targeting RNA With Peptidomimetic Oligomers in Human Cells. Bioorganic and Medicinal Chemisitry Lettrs, 11(4):505-507.
Pankuch et al., N-Me-pAB-Glu-gamma-Glu-gamma-Tyr(3-NO2), An Internally Quenched Fluorogenic Gamma-Glutamyl Hydrolase Substrate. Bioorganic and Medicinal Chemistry Letters, 11(12):1561-1564 (2001).
Hintermann et al., Gamma-Peptides Forming More Stable Secondary Structures Than Alpha-Peptides: Synthesis and Helical NMR-Solution Structure of the Hexapeptide Analog of H-Val-Ala-Leu-2OH. Helvetica Chimica Acta., 81:983-1002 (1998).
Boeijen et al., Solid Phase Synthesis of Oligourea Peptidomimetics. Euro. J. Organic Chem. 9:2127-21135 (1999).
Hemmerlin et al., Helix-Forming Oligoureas: Temperature-Dependent NMR, Structure Determination, and Circular Dichroism of a Nonamer With Functionalized Side Chains. 85(11):3692-3711 (2002).
Patch and Barron, Mimicry of Bioactive Peptides Via Non-Natural, Sequence-specific Peptidomimetic Oligomers, Current Opinion in Chemical Biology, 6:872-877 (2002).
Hamuro et al., De Novo Design of Antibacteral β-Peptides, J. Am. Chem. Soc., 121:12200-12201 (1999).
Liu et al., De Novo Design, Synthesis, and Characterization of Antimicrobial β-Peptides, J. Am. Chem. Soc., 123:7553-7559 (2001).
Arvidsson et al., On the Antimicrobial and Hemolytic Activities of Amphiphilic β-Peptides; Chem. Biochem., 2:771-773 (2001).
Porter et al., Non-Haemolytic β-amino-acid Oligomers, Nature, 404:565 (2000).
Porter et al.,Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides, J. Am. Chem. Soc., 124:7324-7330 (2002).
Boeijen, et al., Solid-Phase Synthesis of Oligourea Peptidomimetics Employing the Fmoc Protection Strategy, J. Org. Chem, vol. 66, pp. 8454-8462 (2001).
Guichard Gilles
Lallemand Eliette
Lena Gersande
Renia Laurent
Centre National de la Recherge Scientifique (CNRS)
ImmuPharma (France) SA
Lukton David
McCarter & English LLP
LandOfFree
Compositions and methods for the treatment and prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment and prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment and prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4149953